题名 | A phase 1 study of LJM716 in patients with esophageal squamous cell carcinoma, head and neck cancer, or HER2-overexpressing metastatic breast or gastric cancer | 链接 | http://meetinglibrary.asco.org/content/94405?media=vm&poster=1 |
http://meetinglibrary.asco.org/content/94405?media=vm&poster=1 |